
Metofin-ER 25 Tablet
Marketer
Q Check Speciality Care
Salt Composition
Metoprolol Succinate (23.75mg)
Overview Metofin-ER 25 Tablet
Extended-release metoprolol succinate 25 mg tablets are beta-blockers used to manage hypertension, angina pectoris, and cardiac arrhythmias. They also help prevent migraine recurrence, future myocardial infarctions, and cerebrovascular accidents. This medication may be administered alone or in conjunction with other therapies, with dosage and frequency tailored to the specific condition and its severity. It can be taken with or without food, but consistent daily timing is crucial for optimal efficacy. Full therapeutic benefit may take weeks to manifest, and continuous use might be necessary. Discontinuation can exacerbate underlying conditions; therefore, consistent use is vital even with symptom improvement. Common, typically mild and transient, adverse effects include fatigue, cephalgia, depressive mood, diarrhea, dermatological reactions, bradycardia, dizziness, and nausea. Hypotension or dyspnea may occur in some individuals. Gradual dose escalation minimizes adverse reactions. Consult your physician regarding persistent or bothersome side effects. Prior to initiation, disclose any hepatic impairment. This medication is contraindicated in patients with bradycardia, significant circulatory compromise, severe congestive heart failure, or hypotension. Pregnant or lactating individuals require physician consultation. Individual suitability should be determined by a medical professional, and regular blood pressure monitoring is essential to assess treatment efficacy. Alcohol consumption should be minimized due to potential exacerbation of side effects.
Primary Ingredients of Metofin-ER 25 Tablet
No text provided to rephrase.
Uses of Metofin-ER 25 Tablet
Management of angina pectoris|Cardiac arrhythmia management|Mitigation of myocardial infarction|Hypertension therapy|Migraine prophylaxis
Major Benefits of Metofin-ER 25 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Swallow the Metofin-ER 25 Tablet whole; do not chew, crush, or divide it. This medication can be taken with or without food, but consistent timing is recommended. Minimize consumption of high-fat foods like olive oil, nuts (including Brazil nuts), dark chocolate, butter, and red meat while taking Metofin-ER 25 Tablet.
Common Side effects of Metofin-ER 25 Tablet:
- Tiredness
- Dizziness
- Depression
- Breathlessness
- Headache
- Slow heart rate
- Nausea
- Rash
- Diarrhea
- Hypotension (low blood pressure)
How to use Metofin-ER 25 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Swallow the Metofin-ER 25 Tablet whole; do not crush, chew, or break it. It can be taken with or without food, but consistency is best—take it at the same time each day. To optimize absorption, avoid consuming Metofin-ER 25 Tablet with meals high in fat, including those containing olive oil, nuts (especially Brazil nuts), dark chocolate, butter, or meat.
How Metofin-ER 25 Tablet works:
Extended-release metoprolol succinate 25 mg tablets are a slow-release beta-adrenergic blocking agent targeting cardiac function. Their mechanism involves reducing heart rate and improving the heart's pumping efficiency, thereby enhancing circulatory function.
SAFETY ADVICE
AlcoholUNSAFE
Combining Metofin-ER 25 Tablets with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Extended-release metoformin 25 mg tablets might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release metoformin 25 mg tablets are likely safe for use while breastfeeding. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Extended-release metoformin 25 mg tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Extended-release metformin 25 mg tablets are suitable for patients with renal impairment. No dosage modification is needed for this medication in such individuals.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Metofin-ER 25 mg tablets, as dose modification may be necessary. Physician consultation is recommended.
What if you forget to take Metofin-ER 25 Tablet :
Should you forget a Metofin-ER 25 Tablet dose, take it promptly. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metofin-ER 25 Tablet
| Label | Value |
|---|---|
| Chemical Classification | Alcohols and Phenols |
| Developing Habits | No. |
| Treatment Category | Heart |
